✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

BioCryst Pharmaceuticals, Inc.

Common Name
BioCryst Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
435
Ticker
BCRX
Exchange
Nasdaq
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for rare diseases, with a primary emphasis on hereditary angioedema (HAE). Its commercial ...

BioCryst Pharmaceuticals's Board Composition Data

Explore BioCryst Pharmaceuticals's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026-04-23
Total Board Member Count
10a
Executive Board Member Count
1a
Non-executive Board Member Count
9a
Independent Board Member Count
8a
Non-independent Board Member Count
2a
Female Board Member Count
4a
Male Board Member Count
6a
Non-binary Board Member Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind BioCryst Pharmaceuticals’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. BioCryst Pharmaceuticals's DEF 14A 2025